Resource Library

Search All Resources

  • Clear All
Addressing Transient Elastography (FibroScan): Integrating with HCV Care | Addressing Starting an HCV Clinic at Crow/Northern Cheyenne | August 25, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #elastography  #fibroscan  #hcv elimination  #lummi  

Dr. Justin Iwasaki, the Executive Medical Director at Lummi Tribal Health Center (LTHC), discusses the creation and design considerations of the HCV Elimination Program at the LTHC, and then he provides an overview of FibroScan technology. Also, a team from ...

Date added: 08/25/18

Addressing Transient Elastography (FibroScan): Integrating with HCV Care | August 14, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #elastography  #fibroscan  #liver disease  

Dr. Youssef Barbour, a Liver Specialist at the Alaska Native Medical Center, provides an overview of transient elastography (FibroScan) and the role that it can play in treating liver disease.

Date added: 08/14/18

Addressing Barriers to Hepatitis C Care Faced By Individuals Who Use Drugs (Idaho, Oregon & Washington) | July 25, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #barriers to care  #hcv treatment  #idaho  #oregon  #washington  

In these slides, Dr. Tina Broder from the National Viral Reduction Alliance, Dr. Vanessa McMahan from the People's Harm Reduction Alliance, and Louise Vincent from the Urban Survivors Union, grade the states of Idaho, Oregon and Washington in their ability ...

Date added: 07/25/18

Addressing Barriers to Hepatitis C Care Faced By Individuals Who Use Drugs (Alaska) | July 10, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #alaska  #hcv treatment  

In these slides, Dr. Tina Broder from the National Viral Reduction Alliance, Dr. Vanessa McMahan from the People’s Harm Reduction Alliance, and Louise Vincent from the Urban Survivors Union, grade the state of Alaska in its ability to provide hepatitis ...

Date added: 07/10/18

HCV Treatment in People Receiving MAT | June 25, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv treatment  #mat  #medication assisted treatment  

In these slides, Dr. Jacob Kesner, an Infectious Diseases Pharmacist at Lovelace Medical Center, discusses the relationship between people receiving MAT and HCV treatment, shares his rationale for providing HCV treatment to people receiving MAT and offers best practices for ...

Date added: 06/25/18

HCC Screening and Follow-Up | May 23, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hepatocellular carcinoma  #hepatology  #liver disease  

In these slides, Dr. Pippa Newell, Medical Director of the Liver Cancer Program at the Providence Cancer Center, shares information on the rising number of cases of hepatocellular carcinoma in the U.S. and Indian Country, the advantages and failings of ...

Date added: 05/23/18

HCV and Children | ANTHC Rural Alaska Harm Reduction Initiative | May 8, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #anthc  #hcv and children  #rural harm reduction  

Jacqueline Fridge, the Division Chief of Pediatric Gastroenterology, Hepatology and Nutrition at the University of New Mexico, discusses the prevalence of HCV in children and screening options for children and youth. She also shares ways HCV can be transmitted to ...

Date added: 05/8/18

Hepatitis C Linkage to Care | April 25, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv screening  #linkage to care  #patient retention  

Greg Carlson, a Nurse with United Indian Health Services, shares detailed information and strategies for retaining HCV patients in care until they have reached a cure.

Date added: 04/25/18

Considerations for Age Expanded Hepatitis C Testing: 2018 | April 10, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv epidemiology  #hcv screening  

Dr. Brian McMahon, Director of the Liver Disease and Hepatitis Program at ANTHC, discusses the epidemiology of HCV, who should be screened to detect chronic HCV infection, and the potential of screening beyond CDC recommendations.

Date added: 04/10/18

Liver Fibrosis Staging | Cherokee Nation Health Services HCV Elimination Program | March 28, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #fibrosis staging  #hcv elimination  #liver disease  #liver fibrosis  

In the first set of slides, Dr. Paulina Deming, Associate Professor of Pharmacy at the University of New Mexico Sciences Center, describes the stages of hepatitis C related liver disease and identifies non-invasive liver fibrosis staging methods. In the second ...

Date added: 03/28/18